T1	CHEM 57 68	sildenafilo
#1	AnnotatorNotes T1	C0529793; sildenafil; Organic Chemical · Pharmacologic Substance
T2	ANAT 76 96	vasos de la placenta
T3	CHEM 154 165	SILDENAFILO
#2	AnnotatorNotes T3	C0529793; sildenafil; Organic Chemical · Pharmacologic Substance
T4	ANAT 172 183	TROFOBLASTO
#3	AnnotatorNotes T4	C0041178; trophoblast; Embryonic Structure | C1285047; Entire trophoblast; Embryonic Structure
T5	ANAT 233 241	vascular
#4	AnnotatorNotes T5	C0005847; Blood Vessel; Body Part, Organ, or Organ Component | C0042591; Vessel Positions; Body Location or Region
T6	CHEM 246 257	sildenafilo
#5	AnnotatorNotes T6	C0529793; sildenafil; Organic Chemical · Pharmacologic Substance
T7	PROC 325 363	estudio longitudinal con grupo control
T8	PROC 633 666	interrupción legal de su embarazo
T9	CHEM 441 463	citrato de sildenafilo
T10	ANAT 498 509	placentaria
#6	AnnotatorNotes T10	C0032043; Placenta; Embryonic Structure
T11	DISO 772 798	complicaciones obstétricas
T12	DISO 901 918	Aborto recurrente
#7	AnnotatorNotes T12	C0000809; Abortion, Habitual; Disease or Syndrome
T13	DISO 942 968	enfermedades hematológicas
#8	AnnotatorNotes T13	C0018939; Hematological Disease; Disease or Syndrome
T14	CHEM 978 998	fármacos vasoactivos
#9	AnnotatorNotes T14	C0597639; vasoactive agent; Pharmacologic Substance
T15	DISO 1036 1048	hipertensión
#10	AnnotatorNotes T15	C0020538; Hypertensive disease; Disease or Syndrome
T16	DISO 1051 1078	Abuso de sustancias tóxicas
T17	DISO 1083 1112	Síntomas de amenaza de aborto
#11	AnnotatorNotes T17	C0740685; ABORTION THREATENED SYMPTOMS; Sign or Symptom
T18	CHEM 1139 1150	sildenafilo
#12	AnnotatorNotes T18	C0529793; sildenafil; Organic Chemical · Pharmacologic Substance
T19	PROC 396 410	administración
#13	AnnotatorNotes T19	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T20	DISO 920 932	preeclampsia
#14	AnnotatorNotes T20	C0032914; Pre-Eclampsia; Pathologic Function
T21	Date 13 17	2017
T22	LIVB 184 190	HUMANO
#15	AnnotatorNotes T22	C0086418; Homo sapiens; Human
T23	PHYS 264 273	gestación
#16	AnnotatorNotes T23	C0032961; Pregnancy; Organism Function
T24	LIVB 350 363	grupo control
#17	AnnotatorNotes T24	C0009932; Control Group; Group
T26	Dose 414 437	una dosis única de 50mg
T29	Date 513 532	el primer trimestre
T30	PHYS 536 545	embarazos
#18	AnnotatorNotes T30	C0032961; Pregnancy; Organism Function
T31	LIVB 557 576	mujeres embarazadas
#19	AnnotatorNotes T31	C0033011; Pregnant Women; Population Group
T32	Duration 577 603	por debadjo de doce semana
T33	PHYS 658 666	embarazo
#20	AnnotatorNotes T33	C0032961; Pregnancy; Organism Function
T34	LIVB 700 725	Mujeres sanas embarazadas
#21	AnnotatorNotes T34	C0033011; Pregnant Women; Population Group + C1708335; Healthy Volunteers; Population Group
T35	Age 726 742	entre 20-40 años
T36	PHYS 748 756	Embarazo
#22	AnnotatorNotes T36	C0032961; Pregnancy; Organism Function
T37	Neg_cue 768 771	sin
T38	Date 824 840	primer trimestre
T40	Neg_cue 1196 1203	excepto
T41	PHYS 1207 1215	embarazo
#23	AnnotatorNotes T41	C0032961; Pregnancy; Organism Function
T43	PHYS 714 725	embarazadas
#24	AnnotatorNotes T43	C0032961; Pregnancy; Organism Function
T42	PHYS 809 820	gestacional
#25	AnnotatorNotes T42	C0032961; Pregnancy; Organism Function
T27	PHYS 565 576	embarazadas
#26	AnnotatorNotes T27	C0032961; Pregnancy; Organism Function
T44	PHYS 226 241	efecto vascular
#27	AnnotatorNotes T44	C2755848; vascular tissue development; Organ or Tissue Function
T45	PHYS 482 509	vascularización placentaria
#28	AnnotatorNotes T45	C2755848; vascular tissue development; Organ or Tissue Function
T25	PROC 804 820	Edad gestacional
#29	AnnotatorNotes T25	C4040272; Assessment of fetal gestational age; Health Care Activity
A1	Assertion T11 Negated
A5	Assertion T41 Negated
A2	Status T20 History_of
A3	Assertion T18 Contraindicated
#30	AnnotatorNotes T2	C0459710; Placental vessel; Body Part, Organ, or Organ Component 
#31	AnnotatorNotes T9	C0724693; sildenafil citrate; Organic Chemical · Pharmacologic Substance 
#32	AnnotatorNotes T8	C0000812; Legal abortion (procedure); Therapeutic or Preventive Procedure 
T28	PROC 365 372	placebo
#33	AnnotatorNotes T28	C0032042; Placebos; Therapeutic or Preventive Procedure
T39	Spec_cue 464 469	puede
T46	CONC 470 478	aumentar
A4	Assertion T46 Speculated
#34	AnnotatorNotes T46	C0442805; Increase; Functional Concept
A6	Assertion T45 Speculated
R1	Speculation Arg1:T39 Arg2:T46	
R2	Speculation Arg1:T39 Arg2:T45	
R3	Location_of Arg1:T10 Arg2:T45	
T47	Observation 882 899	riesgo obstétrico
#35	AnnotatorNotes T47	C3533167; Obstetrical risk; Finding
R4	Negation Arg1:T40 Arg2:T41	
R5	Overlap Arg1:T36 Arg2:T11	
R6	Negation Arg1:T37 Arg2:T11	
T48	Observation 46 52	Efecto
#36	AnnotatorNotes T48	C1518681; Outcome of Therapy; Finding (?)
R7	Causes Arg1:T1 Arg2:T48	
R8	Location_of Arg1:T2 Arg2:T48	
T49	Observation 143 149	EFECTO
#37	AnnotatorNotes T49	C1518681; Outcome of Therapy; Finding (?)
R9	Causes Arg1:T3 Arg2:T49	
R10	Location_of Arg1:T4 Arg2:T49	
R11	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T22	
T50	PROC 120 133;191 198	INVESTIGACIÓN IN VIVO
#38	AnnotatorNotes T50	C0681829; in vivo study; Research Activity
R12	Location_of Arg1:T5 Arg2:T44	
R13	Causes Arg1:T6 Arg2:T44	
R14	Overlap Arg1:T44 Arg2:T23	
T51	Quantifier_or_Qualifier 274 282	temprana
#39	AnnotatorNotes T51	C1279919; Early; Temporal Concept
R16	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T51	
R17	Experiences Arg1:T24 Arg2:T28	
R18	Used_for Arg1:T9 Arg2:T19	
R19	Has_Dose_or_Strength Arg1:T9 Arg2:T26	
R21	Overlap Arg1:T45 Arg2:T29	
R22	Overlap Arg1:T45 Arg2:T30	
T52	Quantifier_or_Qualifier 546 551	sanos
#40	AnnotatorNotes T52	C3898900; Healthy; Qualitative Concept
R23	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T52	
R24	Experiences Arg1:T31 Arg2:T27	
R25	Has_Duration_or_Interval Arg1:T27 Arg2:T32	
R26	Experiences Arg1:T31 Arg2:T8	
R27	Before Arg1:T27 Arg2:T8	
R28	Before Arg1:T33 Arg2:T8	
R29	Experiences Arg1:T31 Arg2:T33	
R30	Experiences Arg1:T22 Arg2:T49	
R32	Experiences Arg1:T24 Arg2:T45	
R33	Experiences Arg1:T24 Arg2:T30	
R34	Has_Age Arg1:T34 Arg2:T35	
R35	Experiences Arg1:T34 Arg2:T43	
#41	AnnotatorNotes T11	C0178292; Complications of pregnancy, childbirth and the puerperium; Pathologic Function
R36	Overlap Arg1:T42 Arg2:T38	
R38	Before Arg1:T13 Arg2:T47	
R39	Before Arg1:T20 Arg2:T47	
R40	Before Arg1:T12 Arg2:T47	
#42	AnnotatorNotes T16	C0740858; Substance abuse problem; Mental or Behavioral Dysfunction
R15	Experiences Arg1:T24 Arg2:T19	
#43	AnnotatorNotes T7	C0023981; Longitudinal Studies; Research Activity + C0681867; Controlled Study; Research Activity
A7	Experiencer T34 Patient
A8	Experiencer T22 Patient
A9	Experiencer T24 Patient
A10	Experiencer T31 Patient
